DAMION RODEBACK: Open Payments
NPI 1083069793 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 17 payments from 6 companies in 2025. Trend: 2023 $91 · 2024 $657 · 2025 $478
Food & beverage: $358Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $270 |
| Janssen Biotech, Inc. | 1 | $95 |
| Biofrontera Inc. | 2 | $44 |
| REVANCE THERAPEUTICS, INC. | 1 | $39 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: SKYRIZI, TREMFYA, DAXXIFY, AMELUZ, RINVOQ, YCANTH, AKLIEF.
Industry payments across UT — which companies pay providers there.
